Skip to main content
. 2020 Oct 19;15:1177271920965522. doi: 10.1177/1177271920965522

Figure 2.

Figure 2.

Biospecimen pathways.

Diagram showing typical biospecimen pathways from patient to research laboratory in 2010s (upper panel) and 2020’s (lower panel). Biospecimens are obtained direct from the patient or through the pathology laboratory with or without a biobank intermediary. With an increase of need for clinical biospecimens to drive biomarkers research, there is an increased appetite for biospecimens from clinical pathology departments and clinical laboratories, such as FFPE blocks and clinical blood samples respectively.